Get the Stockscreener App
36.88
1.05%
-0.39
After Hours:
38.75
1.87
+5.07%
Apogee Therapeutics Inc stock is traded at $36.88, with a volume of 474.54K.
It is down -1.05% in the last 24 hours and up +0.49% over the past month.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
See More
Previous Close:
$37.27
Open:
$37.26
24h Volume:
474.54K
Relative Volume:
0.58
Market Cap:
$1.70B
Revenue:
-
Net Income/Loss:
$-146.66M
P/E Ratio:
-13.39
EPS:
-2.7541
Net Cash Flow:
$-133.21M
1W Performance:
-2.61%
1M Performance:
+0.49%
6M Performance:
-4.28%
1Y Performance:
-25.03%
1-Day Range:
$36.86
$37.94
1-Week Range:
$36.81
$38.84
52-Week Range:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
Name
Apogee Therapeutics Inc
Sector
Industry
Phone
650-394-5230
Address
221 CRESCENT ST., WALTHAM
Compare APGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
36.88 | 2.23B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Reiterated | BTIG Research | Buy |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Nov-25-24 | Initiated | Canaccord Genuity | Buy |
| May-10-24 | Initiated | BofA Securities | Buy |
| Dec-20-23 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | Guggenheim | Buy |
| Aug-08-23 | Initiated | Jefferies | Buy |
| Aug-08-23 | Initiated | Stifel | Buy |
| Aug-08-23 | Initiated | TD Cowen | Outperform |
| Aug-08-23 | Initiated | Wedbush | Outperform |
View All
Apogee Therapeutics Inc Stock (APGE) Latest News
Alliancebernstein L.P. Decreases Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Woodline Partners LP Has $39.64 Million Stock Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Parkman Healthcare Partners LLC Reduces Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics Announces Late-Breaker Presentation of - GlobeNewswire
Apogee Therapeutics Announces Acceptance of Phase 2 APEX Trial Data for APG777 at EADV Congress 2025 - Quiver Quantitative
Apogee Therapeutics to present 16-week phase 2 data on APG777 for atopic dermatitis at EADV 2025 - MarketScreener
First 3-6 Month Dosing Biologic: Apogee's APG777 Shows Best-in-Class Potential for Atopic Dermatitis - Stock Titan
Octagon Capital Advisors LP Makes New Investment in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics Inc. $APGE Shares Sold by Northern Trust Corp - MarketBeat
Adage Capital Partners GP L.L.C. Acquires 486,800 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat
Granahan Investment Management LLC Buys 15,486 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat
Relief Rally in Apogee Therapeutics Inc. Stock — Can It Hold2025 Technical Patterns & Reliable Breakout Forecasts - beatles.ru
Apogee Therapeutics Inc. $APGE Shares Acquired by Allostery Investments LP - MarketBeat
Birchview Capital LP Makes New Investment in Apogee Therapeutics Inc. $APGE - MarketBeat
Is Apogee Therapeutics Inc. stock technically oversold2025 Volatility Report & AI Forecast Swing Trade Picks - 강소기업뉴스
Technical analysis overview for Apogee Therapeutics Inc. stockGold Moves & Reliable Entry Point Alerts - Newser
Does Apogee Therapeutics Inc. meet Warren Buffett’s criteriaWeekly Stock Analysis & Daily Profit Maximizing Tips - خودرو بانک
Rafferty Asset Management LLC Decreases Stock Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Chart Patterns Forming a Bullish Setup in Apogee Therapeutics Inc.2025 Valuation Update & Expert Approved Trade Ideas - beatles.ru
Apogee Therapeutics CMO sells $103,198 in stock By Investing.com - Investing.com Canada
Can technical indicators confirm Apogee Therapeutics Inc.’s reversalJuly 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Using data models to predict Apogee Therapeutics Inc. stock movement2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Relative strength of Apogee Therapeutics Inc. in sector analysisRate Cut & Weekly Breakout Watchlists - Newser
Is Apogee Therapeutics Inc. subject to activist investor interestProfit Target & High Return Trade Opportunity Guides - خودرو بانک
Is Apogee Therapeutics Inc. stock overvalued or fairly pricedJuly 2025 Short Interest & Stepwise Trade Execution Plans - خودرو بانک
Earnings visualization tools for Apogee Therapeutics Inc.2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Paradigm Biocapital Advisors LP Reduces Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Understanding Apogee Therapeutics Inc.’s price movement2025 Price Action Summary & High Conviction Investment Ideas - Newser
Exit strategy if you’re trapped in Apogee Therapeutics Inc.Trade Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Apogee Therapeutics Inc.Weekly Gains Report & Growth Focused Entry Point Reports - Newser
Real time pattern detection on Apogee Therapeutics Inc. stockTrade Ideas & Weekly High Momentum Picks - Newser
Is Now a Good Time to Reenter Apogee Therapeutics Inc.Rate Hike & Daily Technical Stock Forecast Reports - beatles.ru
Is Apogee Therapeutics Inc. stock a smart retirement pickJuly 2025 Levels & Daily Chart Pattern Signal Reports - خودرو بانک
Is Apogee Therapeutics Inc. part of any major indexJuly 2025 Spike Watch & Smart Allocation Stock Reports - خودرو بانک
What technical models suggest about Apogee Therapeutics Inc.’s comebackMarket Activity Summary & Expert Verified Stock Movement Alerts - Newser
Is Apogee Therapeutics Inc. stock a value trapWeekly Risk Report & Free Community Supported Trade Ideas - خودرو بانک
Will Apogee Therapeutics Inc. bounce back from current supportMarket Activity Summary & Daily Technical Stock Forecast Reports - Newser
Can Apogee Therapeutics Inc. outperform under higher oil prices2025 Volume Leaders & Momentum Based Trading Ideas - خودرو بانک
Analyzing drawdowns of Apogee Therapeutics Inc. with statistical toolsPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum - The Manila Times
Apogee Therapeutics to Participate in Stifel Virtual Immunology Forum. - AInvest
Apogee Therapeutics to Present at Stifel 2025 Virtual Immunology and Inflammation Forum - AInvest
Biotech Innovator Apogee Therapeutics Featured at Upcoming Stifel 2025 Immunology Conference - Stock Titan
Long term hold vs stop loss in Apogee Therapeutics Inc.Chart Signals & Weekly High Return Stock Opportunities - Newser
Using R and stats models for Apogee Therapeutics Inc. forecastingJuly 2025 Levels & Real-Time Chart Breakout Alerts - Newser
Institutional scanner results for Apogee Therapeutics Inc.Trade Entry Summary & Technical Pattern Alert System - Newser
Volume spikes in Apogee Therapeutics Inc. stock – what they meanTrade Analysis Summary & Safe Capital Growth Trade Ideas - Newser
Risk adjusted return profile for Apogee Therapeutics Inc. analyzedTrade Signal Summary & Risk Managed Investment Strategies - Newser
Apogee Therapeutics Inc Stock (APGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):